Literature DB >> 6703192

Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors.

L M Weiss.   

Abstract

A series of 43 adrenocortical tumors was analyzed using nine histologic features. Mitotic activity, especially with atypical forms, and venous invasion correlated best with metastasizing or recurring tumors; however, no single criterion was useful alone. The combination of the following nine criteria was most useful in distinguishing malignant from benign tumors: nuclear grade III or IV; mitotic rate greater than 5/50 high-power fields; atypical mitoses; clear cells comprising 25% or less of the tumor; a diffuse architecture; microscopic necrosis; and invasion of venous, sinusoidal, and capsular structures. None of the 24 tumors with two or less of these criteria metastasized or recurred, while all but one of the 19 tumors with four or more of these criteria either recurred or metastasized.

Entities:  

Mesh:

Year:  1984        PMID: 6703192     DOI: 10.1097/00000478-198403000-00001

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  188 in total

Review 1.  Current perspective in the diagnosis and treatment of adrenocortical carcinoma.

Authors:  D E Schteingart
Journal:  Rev Endocr Metab Disord       Date:  2001-08       Impact factor: 6.514

Review 2.  FDG PET in the management of patients with adrenal masses and adrenocortical carcinoma.

Authors:  Désirée Deandreis; Sophie Leboulleux; Caroline Caramella; Martin Schlumberger; Eric Baudin
Journal:  Horm Cancer       Date:  2011-12       Impact factor: 3.869

3.  Monoclonal Antibodies Recognizing Normal and Neoplastic Human Adrenal Cortex.

Authors:  Carin Backlin; Claes Juhlin; Lars Grimelius; Kristina Wiberg; Per Heilman; Goran Akerstrom; Jonas Rastad
Journal:  Endocr Pathol       Date:  1995       Impact factor: 3.943

Review 4.  Aldosterone-secreting adrenal cortical carcinoma. A case report and review of the literature.

Authors:  Adrienne Carruth Griffin; Rachel Kelz; Virginia A LiVolsi
Journal:  Endocr Pathol       Date:  2014-09       Impact factor: 3.943

5.  Genomic and immunohistochemical analysis in human adrenal cortical neoplasia reveal beta-catenin mutations as potential prognostic biomarker.

Authors:  Alexandra E Kovach; Carmelo Nucera; Quynh T Lam; Ahnthu Nguyen; Dora Dias-Santagata; Peter M Sadow
Journal:  Discoveries (Craiova)       Date:  2015 Apr-Jun

6.  Adrenal cortical diseases: international case conference.

Authors:  Hironobu Sasano; Takashi Suzuki; Junji Irie; Kioko Kawai; Motohiko Aiba; Anne Marie McNicol; Hiroshi Takami
Journal:  Endocr Pathol       Date:  2002       Impact factor: 3.943

7.  N-cadherin expression in adrenal tumors: upregulation in malignant pheochromocytoma and downregulation in adrenocortical carcinoma.

Authors:  Amir Khorram-Manesh; Håkan Ahlman; Svante Jansson; Ola Nilsson
Journal:  Endocr Pathol       Date:  2002       Impact factor: 3.943

Review 8.  A case of normoreninemic aldosterone-producing adenoma associated with chronic renal failure: case report and literature review.

Authors:  Hiroyuki Koshiyama; Takeshi Fujisawa; Naomitsu Kuwamura; Yoshio Nakamura; Hiroshi Kanamori; Emi Oida; Akira Hara; Takashi Suzuki; Hironobu Sasano
Journal:  Endocrine       Date:  2003-08       Impact factor: 3.633

Review 9.  [Adrenocortical tumours].

Authors:  W Saeger
Journal:  Pathologe       Date:  2003-05-06       Impact factor: 1.011

10.  Giant non-functional adrenal adenoma: A case report.

Authors:  Baozhong Li; Qingqu Guo; Haijun Yang; Jianyun Guan
Journal:  Oncol Lett       Date:  2012-10-19       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.